Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Homozygosity Mapping and Targeted Sanger Sequencing Identifies Three Novel Crb1 (Crumbs Homologue 1) Mutations in Iranian Retinal Degeneration Families Publisher Pubmed



Ghofrani M1, 2 ; Yahyaei M1 ; Brunner HG2 ; Cremers FPM2, 3 ; Movasat M4 ; Imran Khan M2 ; Keramatipour M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands
  3. 3. Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, Netherlands
  4. 4. Eye Research Center, Tehran University of Medical Sciences, Farabi Eye Hospital, Tehran, Iran

Source: Iranian Biomedical Journal Published:2017


Abstract

Background: Inherited retinal diseases (IRDs) are a group of genetic disorders with high degrees of clinical, genetic and allelic heterogeneity. IRDs generally show progressive retinal cell death resulting in gradual vision loss. IRDs constitute a broad spectrum of disorders including retinitis pigmentosa and Leber congenital amaurosis. In this study, we performed genotyping studies to identify the underlying mutations in three Iranian families. Methods: Having employed homozygosity mapping and Sanger sequencing, we identified the underlying mutations in the crumbs homologue 1 gene. The CRB1 protein is a part of a macromolecular complex with a vital role in retinal cell polarity, morphogenesis, and maintenance. Results: We identified a novel homozygous variant (c.1053_1061del; p.Gly352_Cys354del) in one family, a combination of a novel (c.2086T>C; p.Cys696Arg) and a known variant (c.2234C>T, p.Thr745Met) in another family and a homozygous novel variant (c.3090T>A; p.Asn1030Lys) in a third family. Conclusion: This study shows that mutations in CRB1 are relatively common in Iranian non-syndromic IRD patients. © 2017, Pasteur Institute of Iran. All rights reserved.